SCHEMBL4455633

SCHEMBL4455633

NC1=NC(N)(Cc2cc(-c3cccs3)no2)NC=C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.40
DRD4 P21917 7/20 0.40
DRD3 P35462 7/20 0.40
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
NPC1 O15118 1/20 0.33
HSD17B10 Q99714 1/20 0.33
IGF1R P08069 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 1/20 0.32
TDO2 P48775 1/20 0.32
CCNE2 O96020 1/20 0.31
CCNE1 P24864 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4460763 0.81 NOTUM (0.50) DRD2DRD4DRD3CYP1A2CYP2C9
SCHEMBL4464376 0.78 CA12 (0.38) CA12CA9CYP1A2NPC1IGF1R
SCHEMBL4464611 0.74 SMN1; SMN2 (0.47) CA12CA9CYP1A2CYP3A4CYP2C9
SCHEMBL4457103 0.70 TAAR1 (0.42) HSD17B10SMN1; SMN2ALDH1A1HPGDTDP1
SCHEMBL15029059 0.69 CA12 (0.49) DRD2DRD4DRD3CA12CA9
SCHEMBL14896296 0.67 HSD17B10 (0.50) DRD2DRD4DRD3CA12CA9
SCHEMBL5732649 0.66 CA12 (0.49) DRD2DRD4DRD3CA12CA9
SCHEMBL4466582 0.65 MAPT (0.36) CYP2C9HSD17B10ALDH1A1MEN1MAPT
SCHEMBL7020024 0.64 KDM4E (0.47) DRD2DRD4DRD3CA12CA9
SCHEMBL6768359 0.64 DRD2 (0.49) DRD2DRD4DRD3CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO disclosed